GO:0017128 phospholipid scramblase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0017128 phospholipid scramblase activity describes the ATP-independent catalysis of phospholipid movement between the two leaflets of a membrane bilayer.
• Phospholipid scramblases collapse the asymmetric distribution of phosphatidylserine and other phospholipids, a key event in apoptosis, platelet activation and membrane repair.
• TMEM16F (ANO6) is the best-characterized Ca2+-activated scramblase; its loss causes Scott syndrome, a bleeding disorder.
• VDAC dimers and CLCC1 have been reported to display scramblase activity at mitochondria and the endoplasmic reticulum, linking the activity to autophagy, cell death and lipid homeostasis.
• Fluorescence-based assays using labeled phospholipids in reconstituted vesicles are the standard way to measure scramblase activity in vitro.
• CRISPR knockout, point-mutation and knock-in models are essential to test whether a candidate gene is causally required for phospholipid scrambling in cells.
Description
Phospholipid scramblase activity (GO:0017128) is a molecular function that catalyzes the movement of phospholipids from one membrane bilayer leaflet to the other by an ATP-independent mechanism. Biological membranes are normally asymmetric, with phosphatidylserine (PS) and phosphatidylethanolamine concentrated on the inner leaflet and phosphatidylcholine and sphingomyelin on the outer leaflet. Scramblases dissipate this asymmetry, allowing phospholipids to equilibrate between leaflets. This activity is central to processes such as apoptotic cell clearance, platelet procoagulant activity and membrane repair. The functional importance of phospholipid scramblase activity was first recognized in platelets, where Ca2+-dependent PS exposure supports blood coagulation. Subsequent work identified TMEM16F (ANO6) as an essential Ca2+-activated scramblase mutated in Scott syndrome. More recently, scramblase activity has been attributed to additional proteins, including VDAC dimers at mitochondria and CLCC1 at the endoplasmic reticulum, expanding the biological scope of GO:0017128 to autophagy, cell death and lipid homeostasis. For researchers, GO:0017128 provides a precise functional annotation for genes whose products move phospholipids across bilayers without ATP hydrolysis. Because scramblase activity is often inferred from cellular phenotypes such as PS exposure, direct biochemical assays in reconstituted systems are required to assign the activity confidently. This article summarizes the mechanism, key genes, disease links and experimental methods for studying phospholipid scramblase activity.
phospholipid scramblase activity At A Glance
| GO ID | GO:0017128 |
|---|---|
| GO term | phospholipid scramblase activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Catalysis of the movement of phospholipids from one membrane bilayer leaflet to the other, by an ATP-independent mechanism. |
| Major function | ATP-independent transbilayer movement of phospholipids, collapsing membrane lipid asymmetry. |
| Directionality | Bidirectional equilibration of phospholipids between bilayer leaflets. |
| Energy requirement | ATP-independent. |
| Representative proteins | TMEM16F (ANO6), VDAC dimers, CLCC1, and other candidate scramblases. |
What Is GO:0017128?
Phospholipid scramblase activity (GO:0017128) is defined as the catalysis of phospholipid movement from one membrane bilayer leaflet to the other by an ATP-independent mechanism. In other words, it is a protein function that allows phospholipids to flip between the inner and outer surfaces of a membrane without consuming ATP, thereby reducing or abolishing the normal transverse asymmetry of the bilayer.
Why Is phospholipid scramblase activity Important in Cell Biology?
Phospholipid scramblase activity is important because it controls the exposure of phosphatidylserine and other phospholipids on the cell surface, which acts as a signal for apoptotic cell clearance, blood coagulation and membrane repair. Defects in this activity cause human disease, most notably Scott syndrome, a bleeding disorder caused by mutations in TMEM16F (ANO6). In addition, scramblase activity at mitochondria and the endoplasmic reticulum has been linked to autophagy, cell death and lipid homeostasis, making GO:0017128 relevant to cancer biology, neurodegeneration and ageing research.
• Controls phosphatidylserine exposure, a key eat-me signal for apoptotic cell clearance by macrophages.
• Supports platelet procoagulant activity and normal hemostasis; loss of function causes Scott syndrome.
• Contributes to membrane repair and remodeling in response to cell stress.
• Links mitochondrial function to cell death and autophagy through VDAC dimer scramblase activity.
• Maintains endoplasmic reticulum lipid homeostasis via CLCC1.
• Provides a druggable target concept for anoctamin pharmacology, including TMEM16F modulators.
• Serves as a functional readout in reconstituted vesicle assays for gene function assignment.
• Is relevant to cancer, neurodegeneration and ageing through dysregulated lipid asymmetry.
Molecular Mechanism of phospholipid scramblase activity
Substrate recognition and bilayer leaflet access
In simple terms: The scramblase must first reach phospholipids buried in the membrane.
Phospholipid scramblases act on phospholipid substrates within the membrane bilayer, allowing them to move between the inner and outer leaflets. The activity is ATP-independent, distinguishing it from ATP-driven flippases that move specific lipids unidirectionally. In reconstituted systems, scramblase activity can be measured using fluorescent phospholipid analogs that report transbilayer movement.
Catalytic transbilayer movement
In simple terms: The protein provides a path for lipids to flip across the membrane.
The catalytic event is the movement of a phospholipid from one leaflet to the other, which can occur bidirectionally and does not require ATP hydrolysis. For TMEM16F (ANO6), Ca2+ binding activates the protein to support phospholipid scrambling, and loss-of-function mutations impair this activity in Scott syndrome. VDAC dimers have also been reported to display phospholipid scramblase activity, linking the function to mitochondrial membranes.
Calcium-dependent activation
In simple terms: Calcium acts as a switch for some scramblases.
TMEM16F is a Ca2+-activated scramblase, and anoctamin pharmacology studies have characterized modulators that affect its activity. Calcium-dependent scrambling is central to platelet activation, where PS exposure supports coagulation factor assembly. This regulation distinguishes Ca2+-gated scramblases from constitutively active or stress-induced scramblases.
Membrane composition and assay reconstitution
In simple terms: The lipid environment and reconstitution method affect measured activity.
Scramblase activity assays often require reconstitution of purified proteins into unilamellar vesicles with defined lipid compositions. Fluorescence-based assays using labeled phospholipids are widely used to quantify transbilayer movement in vitro. One-pot reconstitution of GPCRs into unilamellar vesicles has been adapted for fluorescence-based phospholipid scramblase activity assays, illustrating the importance of membrane environment.
Downstream consequences of lipid asymmetry loss
In simple terms: Flipping lipids changes cell surface signals.
Loss of lipid asymmetry exposes phosphatidylserine on the outer leaflet, which serves as a signal for apoptotic cell clearance. In platelets, PS exposure supports procoagulant activity, and defects in this process cause bleeding. At the endoplasmic reticulum, CLCC1 governs bilayer equilibration to maintain lipid homeostasis, showing that scramblase-related activity affects organelle function.
Key Genes Involved in GO:0017128 phospholipid scramblase activity
The following genes and proteins have been directly implicated in phospholipid scramblase activity or in the regulation of transbilayer phospholipid movement.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TMEM16F (ANO6) | Ca2+-activated phospholipid scramblase | Mutations cause Scott syndrome; target for anoctamin pharmacology |
| VDAC1/VDAC2/VDAC3 | Voltage-dependent anion channels forming dimers with scramblase activity | Links mitochondrial scramblase activity to cell death, autophagy and ageing |
| CLCC1 | Endoplasmic reticulum protein governing bilayer equilibration | Maintains ER lipid homeostasis; implicated in lipid-related stress |
| ANO1 (TMEM16A) | Anoctamin family member with Ca2+-dependent functions | Studied in anoctamin pharmacology; related to TMEM16F |
| ANO3-ANO10 | Anoctamin family members | Potential scramblase or related lipid transport functions |
| XKR8 | Apoptotic scramblase | Required for phosphatidylserine exposure during apoptosis |
| PLSCR1 | Phospholipid scramblase family member | Historically named scramblase; used in early activity studies |
| PLSCR2 | Phospholipid scramblase family member | Candidate scramblase with unclear physiological role |
| PLSCR3 | Phospholipid scramblase family member | Candidate scramblase with unclear physiological role |
| PLSCR4 | Phospholipid scramblase family member | Candidate scramblase with unclear physiological role |
| ATP11A | Flippase that opposes scramblase activity | Loss of flippase activity contributes to PS exposure |
| ATP11C | Flippase that opposes scramblase activity | Loss of flippase activity contributes to PS exposure |
| XKR4 | XK-related protein family member | Candidate scramblase in apoptotic and stress responses |
| XKR9 | XK-related protein family member | Candidate scramblase in apoptotic and stress responses |
| TMEM16F mutants | Disease-associated variants | Used to model Scott syndrome and test rescue |
| CLCC1 mutants | ER lipid homeostasis variants | Used to study ER bilayer equilibration |
| VDAC dimer interface mutants | Mitochondrial scramblase variants | Used to test cell death and autophagy phenotypes |
| ANO6 pharmacology targets | Drug-binding sites on TMEM16F | Used in anoctamin pharmacology studies |
How Is phospholipid scramblase activity Regulated?
Phospholipid scramblase activity is regulated by calcium for Ca2+-activated scramblases such as TMEM16F (ANO6), whose activity is switched on by Ca2+ binding and modulated by pharmacological agents. In apoptotic cells, scramblase activity is coordinated with caspase-dependent pathways that inactivate flippases and activate XKR8, leading to phosphatidylserine exposure. At mitochondria, VDAC dimer scramblase activity has been linked to cell death, autophagy and ageing pathways. At the endoplasmic reticulum, CLCC1 governs bilayer equilibration to maintain lipid homeostasis, indicating organelle-specific regulation.
phospholipid scramblase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TMEM16F (ANO6) | Scott syndrome; defective platelet procoagulant activity | Knockout and point-mutation cell models; platelet-like cells |
| XKR8 | Apoptotic cell clearance; autoimmunity | Knockout cells treated with apoptotic stimuli |
| VDAC1/2/3 | Cell death, autophagy and ageing | Dimer-interface point mutants; mitochondrial assays |
| CLCC1 | ER lipid homeostasis; lipid-related stress | Knockout and knock-in ER stress models |
| ANO6 pharmacology targets | Bleeding disorders; anoctamin drug discovery | Overexpression and point-mutation models for drug testing |
Scott syndrome and bleeding disorders
Scott syndrome is a rare bleeding disorder caused by loss-of-function mutations in TMEM16F (ANO6), which impair Ca2+-activated phospholipid scramblase activity and platelet procoagulant activity. Patients show defective phosphatidylserine exposure on platelets, leading to impaired thrombin generation. Anoctamin pharmacology studies have characterized modulators of TMEM16F that could inform therapeutic strategies.
Apoptosis and cancer
Phosphatidylserine exposure by scramblases is a key signal for apoptotic cell clearance, and defects in this process can contribute to autoimmunity and inflammation. In cancer, dysregulated lipid asymmetry and scramblase activity may affect tumor cell survival and immune recognition. VDAC dimer scramblase activity has been linked to cell death pathways relevant to cancer biology.
Neurodegeneration and ageing
Mitochondrial scramblase activity of VDAC dimers has been implicated in cell death, autophagy and ageing, processes relevant to neurodegeneration. Endoplasmic reticulum lipid imbalance governed by CLCC1 may also contribute to stress responses linked to neurodegenerative disease. These findings suggest that phospholipid scramblase activity is relevant to neuronal survival and ageing.
From phospholipid scramblase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for Ca2+-dependent PS exposure? | CRISPR knockout cell line with fluorescence PS exposure assay |
| Does a disease variant impair scramblase activity? | Point-mutation knock-in of the variant, followed by vesicle reconstitution assay |
| Can a wild-type gene rescue a scramblase defect? | Knock-in or overexpression rescue in knockout background |
| Where does the protein localize during scrambling? | Tagged knock-in with fluorescence imaging |
| Does the protein directly move phospholipids? | Purified protein reconstituted into unilamellar vesicles |
| Does scramblase activity affect autophagy or cell death? | Knockout and overexpression models with autophagy/cell death readouts |
How to Study the phospholipid scramblase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence-based scramblase assay | Transbilayer movement of labeled phospholipids | In vitro activity measurement |
| Vesicle reconstitution assay | Direct scramblase activity of purified protein | Assigning GO:0017128 to a gene product |
| Annexin V binding | Phosphatidylserine exposure on cell surface | Apoptosis and platelet activation studies |
| CRISPR knockout | Requirement of a gene for scrambling | Causal gene function testing |
| Point-mutation knock-in | Effect of disease variants on activity | Scott syndrome variant modeling |
| Tagged knock-in imaging | Subcellular localization during scrambling | Organelle-specific studies |
| Autophagy/cell death assays | Downstream consequences of scramblase activity | Mitochondrial scramblase studies |
| Lipidomics | Changes in lipid distribution and homeostasis | ER lipid homeostasis studies |
Fluorescence-based scramblase assays
Fluorescence-based assays using labeled phospholipids are standard for measuring phospholipid scramblase activity in vitro. These assays can be performed in reconstituted unilamellar vesicles, including one-pot reconstitution of GPCRs adapted for scramblase activity measurements. They provide direct biochemical evidence for transbilayer lipid movement.
Vesicle reconstitution and lipid composition control
Reconstitution of purified proteins into unilamellar vesicles allows control of lipid composition and membrane curvature, which influence scramblase activity. This approach is essential to distinguish direct scramblase activity from indirect cellular effects.
Cellular PS exposure assays
Annexin V binding and related fluorescence assays measure phosphatidylserine exposure on the cell surface, a downstream consequence of scramblase activity. These assays are widely used in apoptosis and platelet activation studies.
Genetic and pharmacological perturbation
CRISPR knockout, point-mutation and overexpression models combined with anoctamin pharmacology tools allow causal testing of scramblase function. Such experiments help assign GO:0017128 to specific gene products and link them to disease phenotypes.
How CRISPR Can Be Used to Study GO:0017128 phospholipid scramblase activity
Knockout
CRISPR knockout of candidate scramblase genes such as TMEM16F (ANO6) abolishes Ca2+-dependent phospholipid scrambling and PS exposure, providing causal evidence for GO:0017128. Knockout models are also used to test whether VDAC or CLCC1 loss affects mitochondrial or ER lipid homeostasis.
Point Mutation
Point-mutation knock-in of disease-associated variants, such as TMEM16F mutations found in Scott syndrome, allows precise testing of how single amino acid changes impair scramblase activity. Such models are valuable for structure-function studies of the catalytic mechanism.
Knock-in
Knock-in of tagged or wild-type alleles can rescue scramblase defects and enable localization studies. Tagged knock-in models help determine whether a protein acts at the plasma membrane, mitochondria or endoplasmic reticulum.
Overexpression
Overexpression of candidate scramblases in cells or reconstituted systems can enhance phospholipid scrambling and facilitate biochemical purification for vesicle assays. Overexpression is also used in anoctamin pharmacology to test modulator effects.
How EDITGENE Supports phospholipid scramblase activity Research
Researchers studying phospholipid scramblase activity-related genes often need to determine whether a candidate gene is causally involved in transbilayer phospholipid movement, and whether specific variants alter that function. EDITGENE provides CRISPR-based cell model services that enable precise knockout, point-mutation, knock-in and overexpression studies of GO:0017128-related genes.
Contact EDITGENE today to design your custom CRISPR model for phospholipid scramblase activity research.
Frequently Asked Questions About phospholipid scramblase activity
What is phospholipid scramblase activity?
Phospholipid scramblase activity (GO:0017128) is the ATP-independent catalysis of phospholipid movement from one membrane bilayer leaflet to the other.
What genes are involved in phospholipid scramblase activity?
Key genes include TMEM16F (ANO6), XKR8, VDAC isoforms, CLCC1 and PLSCR family members.
What is the GO ID for phospholipid scramblase activity?
The GO ID is GO:0017128, a molecular_function term.
How is phospholipid scramblase activity measured?
It is measured using fluorescence-based assays with labeled phospholipids, often in reconstituted unilamellar vesicles.
What disease is caused by defective phospholipid scramblase activity?
Scott syndrome, a bleeding disorder, is caused by mutations in TMEM16F (ANO6) that impair scramblase activity.
Is phospholipid scramblase activity ATP-dependent?
No, GO:0017128 is defined as an ATP-independent mechanism.
What is the role of TMEM16F in phospholipid scrambling?
TMEM16F (ANO6) is a Ca2+-activated scramblase required for phosphatidylserine exposure in platelets and other cells.
How do VDAC dimers relate to phospholipid scramblase activity?
VDAC dimers have been reported to display phospholipid scramblase activity, linking them to cell death, autophagy and ageing.
What is CLCC1's function in lipid homeostasis?
CLCC1 governs endoplasmic reticulum bilayer equilibration to maintain lipid homeostasis.
How can CRISPR help study phospholipid scramblase activity?
CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate scramblase genes and disease variants.
Conclusion
Phospholipid scramblase activity (GO:0017128) is a fundamental ATP-independent molecular function that controls transbilayer phospholipid movement and membrane lipid asymmetry. Its roles in apoptosis, platelet activation, mitochondrial function and ER lipid homeostasis make it relevant to bleeding disorders, cancer, neurodegeneration and ageing. Fluorescence-based assays and CRISPR cell models are essential tools for assigning this activity to specific genes and testing disease variants.
References
- 1. Rockenfeller P. 2024. Phospholipid Scramblase Activity of VDAC Dimers: New Implications for Cell Death, Autophagy and Ageing.. Biomolecules 14(10) PMID: 39456151
- 2. Nagata S. 2018. Apoptosis and Clearance of Apoptotic Cells.. Annu Rev Immunol 36:489-517 PMID: 29400998
- 3. Genovese M et al.. 2024. Anoctamin pharmacology.. Cell Calcium 121:102905 PMID: 38788257
- 4. Menon I et al.. 2025. One-Pot Reconstitution of GPCRs into Unilamellar Vesicles for Fluorescence-Based Phospholipid Scramblase Activity Assay.. Methods Mol Biol 2958:255-269 PMID: 40833579
- 5. Bevers EM et al.. 2010. Phospholipid scramblase: an update.. FEBS Lett 584(13):2724-30 PMID: 20302864
- 6. Lhermusier T et al.. 2011. Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome.. J Thromb Haemost 9(10):1883-91 PMID: 21958383
- 7. Wu L et al.. 2026. CLCC1 governs ER bilayer equilibration to maintain lipid homeostasis.. Nature 652(8109):471-480 PMID: 41741642
- 8. Ploier B et al.. 2016. A Fluorescence-based Assay of Phospholipid Scramblase Activity.. J Vis Exp PMID: 27684510
